239 related articles for article (PubMed ID: 26124653)
21. Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.
Ridolo E; Montagni M; Riario-Sforza GG; Baroni M; Incorvaia C
Ther Adv Respir Dis; 2015 Apr; 9(2):49-55. PubMed ID: 25691493
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences.
Ohno T; Wada S; Hanada S; Sawaguchi H; Muraki M; Tohda Y
Int J Chron Obstruct Pulmon Dis; 2014; 9():107-14. PubMed ID: 24489464
[TBL] [Abstract][Full Text] [Related]
23. Computed tomography assessment of airway dimensions with combined tiotropium and indacaterol therapy in COPD patients.
Hoshino M; Ohtawa J
Respirology; 2014 Apr; 19(3):403-10. PubMed ID: 24708031
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.
Buhl R; Gessner C; Schuermann W; Foerster K; Sieder C; Hiltl S; Korn S
Thorax; 2015 Apr; 70(4):311-9. PubMed ID: 25677679
[TBL] [Abstract][Full Text] [Related]
25. Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.
Singh D; Gaga M; Schmidt O; Bjermer L; Grönke L; Voß F; Ferguson GT
Respir Res; 2016 Jun; 17(1):73. PubMed ID: 27316465
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of 12-week or longer indacaterol treatment in moderate-to-severe COPD patients: a systematic review.
Jiang FM; Liang ZA; Zheng QL; Wang RC; Luo J; Li CT
Lung; 2013 Apr; 191(2):135-46. PubMed ID: 23306410
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO
Ferguson GT; Karpel JP; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
Int J Chron Obstruct Pulmon Dis; 2016; 11():2701-2710. PubMed ID: 27843306
[TBL] [Abstract][Full Text] [Related]
28. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.
Girodet PO; Jasnot JY; Le Gros V; Decuypère L; Cao W; Devouassoux G
Respir Med; 2017 Jul; 128():92-101. PubMed ID: 28566230
[TBL] [Abstract][Full Text] [Related]
30. Association between respiratory impedance measured by forced oscillation technique and exacerbations in patients with COPD.
Yamagami H; Tanaka A; Kishino Y; Mikuni H; Kawahara T; Ohta S; Yamamoto M; Suzuki S; Ohnishi T; Sagara H
Int J Chron Obstruct Pulmon Dis; 2018; 13():79-89. PubMed ID: 29317813
[TBL] [Abstract][Full Text] [Related]
31. Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease--a randomized, multicenter, double-blind, placebo-controlled study.
Watz H; Krippner F; Kirsten A; Magnussen H; Vogelmeier C
BMC Pulm Med; 2014 Oct; 14():158. PubMed ID: 25280934
[TBL] [Abstract][Full Text] [Related]
32. Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease.
Bai C; Ichinose M; Lee SH; Lee KH; Jöns O; Bothner U; Zhao Y; Buhl R
Int J Chron Obstruct Pulmon Dis; 2017; 12():3329-3339. PubMed ID: 29200840
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of respiratory impedance in patients with chronic obstructive pulmonary disease by an impulse oscillation system.
Gong SG; Yang WL; Zheng W; Liu JM
Mol Med Rep; 2014 Nov; 10(5):2694-700. PubMed ID: 25189185
[TBL] [Abstract][Full Text] [Related]
34. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.
Kim CJ; Yoon HK; Park MJ; Yoo KH; Jung KS; Park JW; Lim SY; Shim JJ; Lee YC; Kim YS; Oh YM; Kim S; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2017; 12():1589-1596. PubMed ID: 28615931
[TBL] [Abstract][Full Text] [Related]
35. Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol.
Roskell NS; Anzueto A; Hamilton A; Disse B; Becker K
Int J Chron Obstruct Pulmon Dis; 2014; 9():813-24. PubMed ID: 25114521
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis.
Cope S; Zhang J; Williams J; Jansen JP
BMC Pulm Med; 2012 Jun; 12():29. PubMed ID: 22732017
[TBL] [Abstract][Full Text] [Related]
37. Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study.
Beier J; Mroz R; Kirsten AM; Chuecos F; Gil EG
Int J Chron Obstruct Pulmon Dis; 2017; 12():1731-1740. PubMed ID: 28652725
[TBL] [Abstract][Full Text] [Related]
38. A Single Institution Retrospective Study of the Clinical Efficacy of Tiotropium Respimat in Never-Smoking Elderly Asthmatics with Irreversible Airflow Limitation.
Hara J; Kasahara K; Ohkura N; Yamamura K; Sakai T; Abo M; Ogawa N; Saeki K; Koba H; Watanabe S; Uchida Y; Tambo Y; Sone T; Kimura H
Drug Res (Stuttg); 2019 Apr; 69(4):211-217. PubMed ID: 30193393
[TBL] [Abstract][Full Text] [Related]
39. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
40. [Use of forced oscillation technique to detect airflow limitations in adult Japanese asthmatics].
Tsuburai T; Suzuki S; Tsurikisawa N; Mitsui C; Higashi N; Fukutomi Y; Tanimoto H; Sekiya K; Oshikata C; Otomo M; Maeda Y; Taniguchi M; Ikehara K; Akiyama K
Arerugi; 2012 Feb; 61(2):184-93. PubMed ID: 22437728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
